alendronate has been researched along with Substance Withdrawal Syndrome in 2 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Postmenopausal women with breast cancer were randomly assigned to receive alendronate or placebo for 1 year within 3 months after withdrawal of tamoxifen therapy." | 5.13 | Prevention of bone loss after withdrawal of tamoxifen. ( Brown, IN; Cohen, A; Fleischer, JB; Hershman, DL; Joe, AK; Johnson, MK; McMahon, DJ; Silverberg, SJ, 2008) |
| "The aim of the study was to assess the long-term anabolic effect of the parathyroid hormone (PTH) analog SDZ PTS 893 in a dose-response manner, and to determine the ability of the antiresorptive agents estradiol and alendronate to maintain bone mass after withdrawal of SDZ PTS 893." | 1.30 | Long-term therapy of ovariectomy-induced osteopenia with parathyroid hormone analog SDZ PTS 893 and bone maintenance in retired breeder rats. ( Gasser, JA; Mosekilde, LI; Thomsen, JS, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, A | 1 |
| Fleischer, JB | 1 |
| Johnson, MK | 1 |
| Brown, IN | 1 |
| Joe, AK | 1 |
| Hershman, DL | 1 |
| McMahon, DJ | 1 |
| Silverberg, SJ | 1 |
| Thomsen, JS | 1 |
| Mosekilde, LI | 1 |
| Gasser, JA | 1 |
1 trial available for alendronate and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Prevention of bone loss after withdrawal of tamoxifen.
Topics: Absorptiometry, Photon; Administration, Oral; Alendronate; Alkaline Phosphatase; Bone Density; Bone | 2008 |
1 other study available for alendronate and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Long-term therapy of ovariectomy-induced osteopenia with parathyroid hormone analog SDZ PTS 893 and bone maintenance in retired breeder rats.
Topics: Aging; Alendronate; Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Resorption | 1999 |